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Summary
Purpose: To evaluate the number of seizures and interictal epileptiform discharges
(IEDs) in patients with focal neocortical epilepsy before, during and after rTMS.
Methods: Twelve patients (seven men and five women, mean age 29.3  15.8 years)
were studied. An open-label study with baseline (4 weeks), intervention (2 weeks) and
follow-up (8 weeks) periods was carried out. Repetitive transcranial magnetic
stimulation (rTMS) with 900 pulses, intensity of 120% motor resting threshold and
0.5 Hz frequency was used. A 120 channel EEG was recorded; an electrical source
analysis of IEDs with Variable Resolution Electromagnetic Tomography (VARETA) was
performed. The number of seizures per week and IEDs per minute were measured and
compared in the three periods.
Results: During the basal period the mean seizure frequency was 2.25 per week; in
the intervention period it decreased to 0.66 per week (F = 2.825; p = 0.0036) which
corresponds to a 71% reduction. In the follow-up period the mean frequency was
1.14 seizures per week, that is, a 50% reduction in the number of seizures. In the
visual EEG analysis, the baseline IED frequency was 11.9  8.3 events/min; it
decreased to 9.3  7.9 during 2 weeks of rTMS with a further reduction to
8.2  6.6 in the follow-up period. These differences however were not significant
( p = 0.190).* Corresponding author at: Instituto de Neurobiologı´a, Campus UNAM-UAQ, Boulevard Juriquilla 3001, Apdo. Postal 1-1141, Quere´taro
76001, Mexico. Tel.: +52 442 1926103; fax: +52 442 2381046.
E-mail address: santiago@inb.unam.mx (E. Santiago-Rodrı´guez).
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Conclusion: We conclude that 2 weeks of rTMS at 0.5 Hz with a figure-of-eight coil
placed over the epileptic focus, determined with VARETA, decreases the number of
seizures in patients with focal epilepsy, without reduction in IEDs.
# 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Transcranial magnetic stimulation (TMS) is a novel,
simple and non-invasive technique that enables
changes in the excitability of different cortical
areas. Many characteristics of TMS such as coil form,
position, frequency and intensity of the stimulus are
important for the effect of rTMS on cortical excit-
ability.1
In human studies, low-frequency repetitive tran-
scranial magnetic stimulation (rTMS) below 1 Hz
decreases cortical excitability, whereas frequencies
above 5 Hz exert the inverse effect, causing its
enhancement. In the last years, this property has
been applied to study many neurological and psy-
chiatry diseases, as well as coadjuvant treatment in
many of these ailments. In spite of rTMS effective-
ness, its precise mechanism of action has not yet
been established. Long-term potentiation and long-
term depression-like mechanisms have been mainly
postulated as responsible for rTMS effects.1—3
Epilepsy is one of the most frequent neurological
diseases; it affects 1—2% of the general population.
Between5and10%epilepticpatients suffermedically
intractable seizures. Several studies using rTMS for
thetreatmentofepilepsyhaveshowndiversedegrees
of seizure control, as well as a decrease in interictal
epileptiform discharges (IEDs) in the EEG.4—14
Focal epilepsies are ideal for the application of
rTMS due to a delimited zone of increased excit-
ability. One aspect that influences rTMS results is
the precise localization of the epileptic focus.
Recently, some non-invasive techniques have been
developed to localize the epileptic focus using high
density EEG and source analysis methods.15 Among
these techniques, Variable Resolution Electromag-
netic Tomography (VARETA)16 is useful in the loca-
lization of EEG source currents in different
neurological disorders, and generalized and focal
epilepsies.17—22 Moreover, different studies with
rTMS have shown more marked effects on neocor-
tical epilepsies on the convexity of the brain than on
mesial temporal lobe epilepsies (MTLEs).6,10—12
Therefore, the aim of this study is to evaluate
the number and duration of seizures, and the num-
ber of IEDs in patients with focal epilepsy, with
epileptic focus in neocortical areas determined
with electrical source analysis before, during and
after the application of rTMS at 0.5 Hz.Materials and methods
Patient population
Twelve patients with focal epilepsy (seven men and
five women, mean age 29.3  15.8 years) were
studied. Only patients with electrical sources of
paroxysmal activity in neocortical regions were
admitted in the study. They received standard phar-
macological treatment without modification of anti-
epileptic drugs (AEDs) for at least 1 month before
the study started; medication changes were not
allowed. All patients and their parents signed an
informed consent form approved by the Institutional
Committee.
Study design
An open-label study with baseline, intervention and
follow-up periods was carried out. The baseline
period lasted 4 weeks, 2 weeks for the intervention
with rTMS and a follow-up period of 8 weeks in
duration. In the basal period, the patient’s relatives
recorded the number and duration of seizures in a
daily report, which continued during intervention
and 8-week follow-up periods. In addition, the num-
ber of IEDs in the EEG in each period was also
recorded.
EEG analysis
A high-resolution EEG with 120 channels for scalp
recordings was used. All EEG recordings were
obtained in a soundproof room using a Multichannel
Medicid System (Neuronic Mexicana, S.A, Me´xico).
Amplifier characteristics were: gain 10,000 dB, low
cut filters at 0.05 Hz and high filters at 70 Hz. One
hundred and twenty referential leads were recorded
using linked earlobes as reference. The impedance
was under 5 kV in all electrodes. The sampling
frequency was 200 Hz.
All EEG phenomena identified as IEDs were
selected for analysis. For this purpose, two neuro-
physiologists (TH and ES-R) reviewed the recordings,
and only those EEG segments on which agreement
was reachedwere used for electrical source analysis.
Spikes and sharp waves were considered IEDs. The
number and mean duration of IEDs in a 1-min free-
artifact period was selected and compared in the
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using repeated measures ANOVA for the analysis.
The localization of the epileptic focus to apply
rTMS was determined with current source analysis of
paroxysmal activity by VARETA.16 This method
imposes diverse amounts of spatial smoothness for
different types of generators selected by a data-
driven search procedure. In addition, in VARETA,
current sources are restricted to gray matter by
the use of a probabilistic mask that prohibits solu-
tions where the mask is zero, i.e., in the CSF or
white matter. The Probabilistic Brain Atlases used in
this study were developed at the Montreal Neuro-
logical Institute (MNI). The mean head used in this
work was obtained by averaging a set of 305 normal
MRI scans transformed to Talairach space. MRIs were
subjected to nonlinear warps to match a set of 50
common landmarks.23,24 The three-concentric
spheres model was fitted to the MNI mean head
by means of a least square algorithm. Coordinates
for each electrode, obtained from brain electric
source analysis (BESA),25 were then used to project
each electrode onto the average skin.
Repetitive transcranial magnetic
stimulation
One daily rTMS session at 0.5 Hz was carried out on
the epileptogenic zone of each patient with a total
of 900 pulses delivered at 110% intensity of the
resting motor threshold (RMT) during a 2-week per-
iod. RMT was obtained with single pulses delivered
with a figure-of-eight coil positioned 458 tangential
to the scalp (Super-Rapid, The Magstim Co., Whit-
land, UK). To obtain the motor evoked potentials
(MEPs), two surface Ag—AgCl electrodes were
placed over the abductor policis brevis (APB)
of the dominant hand in belly-tendon montage
and registered with Neuronic amplifiers (Neuronic,Table 1 Clinical data of patients with focal epilepsy
Patient Gender Years of evolution Age Seizure type
1 M 14 44 CPSGS
2 M 15 17 CPSGS
3 F 40 54 CPSGS
4 M 11 14 CPSGS
5 F 32 43 CPSGS
6 M 7 25 CPSGS
7 M 12 15 CPSGS
8 M 6 14 CPSGS
9 M 10 34 CPSGS
10 F 7 14 CPSGS
11 F 36 54 CPSGS
12 F 0.2 24 CPSGS
CPSGS: complex partial secondarily generalized seizures; CBZ: carba
TPM: topiramate; LEV: levetiracetam; CZP: clonazepam; PB: phenoMe´xico). Amplifier characteristics were: gain
1000 dB, low cut filters at 10 Hz and high filters at
3000 Hz. The optimal motor cortical site was found
by delivering TMS focal single pulses at 70% intensity
of the stimulator until they triggered a suprathres-
hold motor evoked potential above 50 mV in the
contralateral side to stimulation. Once the correct
site was located, the resting motor threshold was
determined by gradually increasing the intensity of
stimulation in 1% steps. All data were analyzed by
repeated measures ANOVA followed by a post hoc
analysis (STATISTICA ’99).Results
All patients presented focal epilepsy and complex
partial secondarily generalized seizures with epi-
leptogenic focus in different brain regions. Nine
patients were under two AED treatment, two
patients were taking one AED and one patient
received three AEDs. The time of evolution of epi-
lepsy was 16.4  11.9 years. Patients exhibited few
adverse effects; one patient complained of head-
ache after rTMS, other showed a light rest tremor in
the hands at the end of the first week of rTMS
treatment, which disappeared to the end of the
rTMS period. One other patient presented a seizure
at the beginning of the rTMS session, but it was not
related to stimulation because this patient suffered
frequently of seizures even before the initiation of
rTMS sessions. Clinical and demographic character-
istics of the patients are summarized in Table 1.
Seizure reduction
During the 4 weeks of the basal period, all patients
had seizures with a mean frequency of 2.25 per
week. This frequency decreased during the inter-Antiepileptic drugs Focus localization with VARETA
CBZ, OXZ Right fronto-temporal
VA, PHT Right fronto-temporal
TPM, PB Right frontal
CZP, VA Right frontal
CZP, VA Left frontal
VA, PHT, LEV Right fronto-temporal
CZP, VA Right fronto-temporal
TPM, PB Right fronto-temporal
VA, PB Left frontal
VA Left fronto-temporal
CZP, TPM Right temporal
PB Right temporal
mazepine; OXZ: oxcarbazepine; VA: valproate; PHT: phenitoine;
barbital.
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Figure 1 Mean number of seizures per week during, baseline, rTMS and follow-up period. Asterisks represent the
significant values when baseline is compared with rTMS and follow-up periods.
Figure 2 Number of seizure-free patients per week during, baseline, rTMS and follow-up period. Asterisks indicate the
significant values when baseline is compared with rTMS and follow-up periods.vention period with rTMS to 0.66 seizures per week
(F = 2.825; p = 0.0036), which corresponded to a
71% reduction. In the first week of intervention with
rTMS, the mean frequency decreased to 0.50 (78%)
and 0.83 (63%) seizures during the second week.
During the follow-up period, the mean frequency
was 1.14 seizures per week, corresponding to 50%
decrease in seizures. After ANOVA post hoc analysis,
a significant decrease was found between baseline
values and those for weeks number 5, 6, 7, 8, 9, 13
and 14 (p = 0.0002, 0.0031, 0.0009, 0.0003, 0.0052,
0.016 and 0.0269, respectively) (Fig. 1).
In the2weeks of rTMS, six patients (50%)were free
of seizures in the first week and eight (66%) in the
second (p = 0.0330). In thefirstweekof the follow-up
period, eight patients (66%) presented no seizures; in
the subsequent week the number of seizure-free
patients decreased again (Fig. 2). During the rTMS
period, nine patients (75%) exhibited a reduction of
50% or more in seizure frequency. Themean duration
of seizures during the baseline period was 2.27 min,
followed by a decrease to 2.05 min duration for the 2
weeks of rTMS and a further decrease to 1.60 min
duration in the follow-up period.
Epileptiform discharges in the EEG
In all patients IEDs consisted of sharp waves and
spikes. The electrical source of IEDs was localized inneocortical regions of the right hemisphere in 67% of
the cases and 33% on the left. The frontal lobe was
affected in 10 patients and the temporal lobe in 2.
All patients had unilateral epileptic focus in cortical
convexity; only one patient presented two epileptic
foci, both in the frontal lobe. An example of a
current source of IED is shown in Fig. 3.
In the visual EEG analysis, the IED baseline fre-
quency was 11.9  8.3 events/min, decreased to
9.3  7.9 at the end of the rTMS period and to
8.2  6.6 in the follow-up period; however, these
differences were not significant ( p = 0.190). The IED
duration in each period remained unchanged after
rTMS; in the baseline period the duration was
0.50  0.19 s, in the 2 weeks of rTMS it was
0.51  0.22 s, and during the follow-up period
0.41  0.12 s ( p = 0.1118) (Fig. 4).Discussion
Some studies on the treatment of epilepsy with rTMS
have shown a decrease in the number of seizures, as
well as a decrease in IEDs registered in the EEG.4—14
The great variability in the results is partly due to
the heterogeneity of study designs, population,
types of epilepsy and rTMS parameters. At the
moment, this problem remains unresolved.26,27 In
the present study, our aim was to increase the
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Figure 3 Localization of the epileptic focus in the left frontotemporal region of patient number nine, using electrical
source analysis with Variable Resolution Electromagnetic Tomography (VARETA).
Figure 4 (A) The number of EEG interictal epileptiform discharges (IED) per minute and (B) IED duration (in s) during
baseline, rTMS and follow-up periods. No significant differences were found.
682 E. Santiago-Rodrı´guez et al.precision in the localization of the epileptic focus
using electrical source analysis of IEDs.15 Our main
finding was the reduction in seizure frequency not
only during the 2 weeks of low-frequency rTMS, but
also in the 3 post-treatment weeks without signifi-
cant differences in electroencephalographic IEDs.
These results are analyzed in the next paragraphs.
Seizure frequency and duration
There was a significant decrease in seizure fre-
quency during the 2 weeks of rTMS (71%) and in
the follow-up period (50%). These data agree with
those found by previous studies in which a mean
decrease in seizures of 50—72% has been
reported.4,5,10,12 In addition, 66% of patients were
seizure-free during the 2 weeks of rTMS and the first
week of follow-up; this percentage decreased in the
following weeks. In contrast, other open-label and
randomized clinical trials (RCTs) found no significant
differences between the basal and follow-up peri-
ods. Theodore et al., in a RCT study,6 described a
major decrease in seizures after rTMS in patients
with neocortical rather than mesial temporal lobe
epilepsy. The suboptimal stimulation in these
patients might explain these results; rTMS fre-
quency was 1 Hz versus 0.5 Hz used in our study.
In an open-label study,11 Kinoshita et al. found no
significant decrease in seizures for extratemporal
lobe epilepsies, but these authors only used 90%
RMT. It is possible, that the intensity used was low
and might explain the weak antiepileptic effect
reported in their study. Similarly, in other RCT
study,14 Cantello et al. found a slight decrease in
the number of seizures after rTMS but with no
significant differences when compared to the
sham-rTMS group. In this study the majority of
patients presented focal neocortical epilepsies.
Besides, although rTMS was 100% RMT, the stimula-
tion was carried out with a circular coil over the
vertex. Possibly the non-focal stimulation delivered
with a circular coil could be the cause of a weak
antiepileptic effect; especially because a significant
decrease in epileptiform abnormalities in the EEG
was found after rTMS.
In the basal period all patients presented one or
more seizures per week. The seizure duration
decreased during the 2 weeks of rTMS and for some
weeks of the follow-up period. This decrease, eval-
uated by a relative of the patient is a soft variable to
measure the degree of control of the seizures,
unlike the diminution in seizure frequency and
the increment in the number of seizure-free
patients reported also in this study.
In our study, a precise targeting of the epileptic
focus was intended. It seems that the majordecrease in the number of seizures was due to a
more accurate localization of the epileptogenic
zone using the current source approach.15 This
ensures that the effect of rTMS applied with a
double-eight coil is delivered over the neuronal
circuits originating the epileptic focus and not over
the spread of epileptic activity. Also, it is possible
that a more precise localization of the epileptic
focus combined with neuronavigation systems (not
used in our study) to place the coil over the head will
further improve the targeting of the epileptic foci.
Previous data suggest that low-frequency rTMS
modulates inhibitory mechanisms decreasing corti-
cal excitability through GABAergic activity. Long-
term depression-like mechanisms have been also
postulated as responsible for a diminution in the
number of seizures.1,3 The permanence of the effect
for 3 weeks after the end of rTMS together with the
slow return to baseline frequency supports this
concept. It would be convenient to evaluate in
future studies the effect of the periodical applica-
tion of rTMS every 4 or 5 weeks.
Epileptiform discharges in the EEG
There was a tendency showing a decrease in IED
frequency, but differences were not significant
given the small size of our sample. In contrast, all
studies in which IEDs were evaluated, a significant
decrease was found after rTMS.5,10,12—14 The notion
that the number of IEDs has a direct relation to the
number of seizures and that an increase in IED
frequency is necessary for the generation of ictal
discharges is controversial. A decrease in IEDs just
before the manifestation of seizures has been
observed in focal epilepsy. In addition, a relation
between seizure control and the number of IEDs has
not been consistent. Similarly, no relation has been
established between irritative epileptogenic zones
and ictal onset regions. Therefore, de Curtis and
Avanzini28 have proposed that IEDs represent an
attempt of neuronal networks to keep cortical exci-
tation at low levels and represent the counterpart of
increased excitability determined by primary epi-
leptogenic dysfunction. The previous concept
agrees with the fact that our patients exhibited a
decrease in seizures but the modification in the
number of IEDs was not significant. Future rTMS
studies using IED analysis and ictal EEG-video
recording could be used to resolve this problem,
given that especially in extra-temporal lobe epilep-
sies the irritative zone is often not the same as the
seizure onset zone.
We conclude that 2 weeks of rTMS at 0.5 Hz with a
figure-of-eight coil placed over the epileptic focus as
determined with electrical source analysis will
Decrease in seizures after rTMS 683decrease the number of seizures in patients with
focal epilepsy, without causing a significant decrease
in IEDs.Acknowledgments
The authors are grateful to Marcela Sa´nchez for her
revision of the English version and to engineers
He´ctor Belmont, Bruno Argueta and David Avila
for technical assistance.References
1. Kobayashi M, Pascual-Leone A. Transcranial magnetic stimu-
lation in neurology. Lancet Neurol 2003;2:145—56.
2. Hallet M. Transcranial magnetic stimulation and the human
brain. Nature 2000;406:147—50.
3. Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM,
Hallett M, et al. Depression of motor cortex excitability by
low-frequency transcranial magnetic stimulation. Neurology
1997;48:1398—403.
4. Tergau F, Naumann U, Paulus W, Steinhoff J. Low-frequency
transcranial magnetic stimulation improves intractable epi-
lepsy. Lancet 1999;353:2209.
5. Menkes DL, Gruenthal M. Low-frequency transcranial mag-
netic stimulation in a patient with focal cortical dysplasia.
Epilepsia 2000;41:240—2.
6. Theodore WH, Hunter K, Chen R, Vega-Bermudez F, Boroo-
jerdi B, Reeves-Tyer P, et al. Transcranial magnetic stimula-
tion for the treatment of seizures: a controlled study.
Neurology 2002;59:560—2.
7. Daniele O, Brighina F, Piazza A, Giglia G, Scalia S, Fierro B.
Low-frequency transcranial magnetic stimulation in patients
with cortical dysplasia: a preliminary study. J Neurol
2003;250:761—2.
8. Brasil-Neto JP, de Araujo DP, Teixeira WA, Arau´jo VP, Boechat-
Barros R. Experimental therapy of epilepsy with transcranial
magnetic stimulation: lack of additional benefit with pro-
longed treatment. Arq Neuropsiquiatr 2004;62:21—5.
9. Misawa S, Kuwabara S, Shibuya K, Mamada K, Hattori T. Low-
frequency transcranial magnetic stimulation for epilepsia
partialis continua due to cortical dysplasia. J Neurol Sci
2005;234:37—9.
10. Fregni F, Thome-Souza S, Bermpohl F, Marcolin MA, Herzog A,
Pascual-Leone A, et al. Antiepileptic effects of repetitive
transcranial magnetic stimulation in patients with cortical
malformations: an EEG and clinical study. Stereotact Funct
Neurosurg 2005;83:57—62.
11. KinoshitaM, IkedaA, BegumT,YamamotoJ,HitomiT, Shibasaki
H. Low-frequency repetitive transcranial magnetic stimula-
tion for seizure suppression in patients with extratemporal
lobe epilepsy–—a pilot study. Seizure 2005;14:387—92.
12. Fregni F, Otachi PT, Do Valle A, Boggio PS, Thut G, Rigonatti
SP, et al. A randomized clinical trial of repetitive transcranial
magnetic stimulation in patients with refractory epilepsy.
Ann Neurol 2006;60:447—55.13. Joo EY, Han SJ, Chung SH, Cho JW, Seo DW, Hong SB. Anti-
epileptic effects of low-frequency repetitive transcranial
magnetic stimulation by different stimulation durations
and locations. Clin Neurophysiol 2007;118:702—8.
14. Cantello R, Rossi S, Varrasi C, Ulivelli M, Civardi C, Bartalini S,
et al. Slow repetitive TMS for drug-resistant epilepsy: clinical
and EEG findings of a placebo-controlled trial. Epilepsia
2007;48:366—74.
15. Plummer C, Harvey AS, Cook M. EEG source localization in
focal epilepsy: Where are we now? Epilepsia 2008;49:201—
2118.
16. Bosch-Bayard J, Valde´s-Sosa P, Virues-Alba T, Aubert-Va´zquez
E, John ER, Harmony T, et al. 3D statistical parametric
mapping of EEG source spectra by means of variable resolu-
tion electromagnetic tomography (VARETA). Clin Electroen-
cephalogr 2001;32:47—61.
17. Ferna´ndez-Bouzas A, Harmony T, Bosch J, Aubert E, Ferna´n-
dez T, Valde´s P, et al. Sources of abnormal EEG activity in the
presence of brain lesions. Clin Electroencephalogr 1999;30:
46—52.
18. Harmony T, Ferna´ndez T, Silva J, Bosch J, Valde´s P, Ferna´n-
dez-Bouzas A, et al. Do specific EEG frequencies indicate
different processes during mental calculation? Neurosci Lett
1999;266:25—8.
19. Ferna´ndez-Bouzas A, Harmony T, Ferna´ndez T, Ricardo-
Garcell J, Casia´n G, Sa´nchez-Conde R. Cerebral blood flow
and sources of abnormal EEG activity (VARETA) in neurocys-
ticercosis. Clin Neurophysiol 2001;112:2281—7.
20. Santiago-Rodrı´guez E, Harmony T, Ferna´ndez-Bouzas A, Her-
na´ndez A, Martı´nez-Lo´pez M, Graef A, et al. EEG source
localization of interictal epileptiform activity in patients
with partial complex epilepsy: comparison between dipole
modeling and brain distributed source models. Clin Electro-
encephalogr 2002;33:42—7.
21. Santiago-Rodrı´guez E, Harmony T, Ferna´ndez-Bouzas A, Her-
na´ndez-Balderas A, Martı´nez-Lo´pez M, Graef A, et al. Source
analysis of polyspike and wave complexes in juvenile myo-
clonic epilepsy. Seizure 2002;11:320—4.
22. Santiago-Rodrı´guez E, Harmony T, Graef A, Garcı´a JC,
Ferna´ndez-Bouzas A, Herna´ndez-Balderas A, et al. Interictal
regional cerebral blood flow and electrical source analysis in
patients with complex partial seizures. Arch Med Res
2006;37:145—9.
23. Evans AC, Collins DL, Mulls SR. 3D statistical neuroanatomical
models from 305 MRI volumes. Proceedings of the IEEE
nuclear science symposium andmedical imaging conference.
1993:1813—7.
24. Mazziotta JC, Toga A, Evans AC, Fox P, Lancaster J. A prob-
abilistic atlas of the human brain: theory and rationale for its
development. Neuroimage 1995;2:89—101.
25. Scherg M. Fundamentals of dipole source potential analysis.
In: Grandori F, Romani G, editors. Auditory evoked electric
and magnetic fields. Topographic mapping and functional
localization. Advances in audiology. Karger: Basel; 1990. p.
40—69.
26. Tassinari CA, Cincotta M, Zaccara G, Michelucci R. Transcra-
nial magnetic stimulation and epilepsy. Clin Neurophysiol
2003;114:777—98.
27. Theodore WH, Fisher R. Brain stimulation for epilepsy. Acta
Neurochir Suppl 2007;97:261—72.
28. de Curtis M, Avanzini G. Interictal spikes in focal epilepto-
genesis. Prog Neurobiol 2001;63:541—67.
